Article Per Year (5 Year)
p-Index From 2021 - 2026
0.562
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran Cermin Dunia Kedokteran
Franklind Matthew
Fakultas Kedokteran dan Ilmu Kesehatan Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Terapi Psoriasis di Era Pandemi COVID-19 Marsha Kurniawan; Franklind Matthew
Cermin Dunia Kedokteran Vol 48, No 7 (2021): Infeksi - [Covid - 19]
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i7.1449

Abstract

Psoriasis merupakan penyakit inflamasi kronis kulit dengan predisposisi genetik dan autoimun yang kuat. Prevalensi psoriasis di seluruh dunia adalah 0,09% sampai 5,1%, bervariasi antar negara. Psoriasis dikarakteristikkan dengan lesi plak eritematosa yang dilapisi skuama tebal putih keabuan, biasanya memiliki predileksi simestris di siku, lutut, trunk, dan scalp. Terapi sebagian besar menggunakan imunomodulator atau imunosupresan untuk psoriasis derajat sedang hingga berat. Sudah terdapat beberapa penelitian efek samping dan rekomendasi dosis obat-obatan di era COVID-19. Penggunaan terapi tersebut dalam era pandemi COVID-19 harus hati-hati dan tetap menjaga imunitas pasien.Psoriasis is a chronic skin inflammatory disease with a strong genetic and autoimmune predisposition. The prevalence of psoriasis worldwide is 0.09% to 5.1%, varies among countries. Psoriasis is characterized by erythematous plaque lesions covered in thick gray-white scales, usually have a symmetrical predilection on the elbows, knees, trunk, and scalp. Immunomodulators or immunosuppressants are commonly used for moderate to severe psoriasis. There have been several studies on side effects and recommendations for the necessary dosage adjustments in the era of the COVID-19 pandemic. Careful use is important to maintain patient's immunity.
Terapi Psoriasis di Era Pandemi COVID-19 Marsha Kurniawan; Franklind Matthew
Cermin Dunia Kedokteran Vol 48 No 7 (2021): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i7.90

Abstract

Psoriasis merupakan penyakit inflamasi kronis kulit dengan predisposisi genetik dan autoimun yang kuat. Prevalensi psoriasis di seluruh dunia adalah 0,09% sampai 5,1%, bervariasi antar negara. Psoriasis dikarakteristikkan dengan lesi plak eritematosa yang dilapisi skuama tebal putih keabuan, biasanya memiliki predileksi simestris di siku, lutut, trunk, dan scalp. Terapi sebagian besar menggunakan imunomodulator atau imunosupresan untuk psoriasis derajat sedang hingga berat. Sudah terdapat beberapa penelitian efek samping dan rekomendasi dosis obatobatan di era COVID-19. Penggunaan terapi tersebut dalam era pandemi COVID-19 harus hati-hati dan tetap menjaga imunitas pasien. Psoriasis is a chronic skin inflammatory disease with a strong genetic and autoimmune predisposition. The prevalence of psoriasis worldwide is 0.09% to 5.1%, varies among countries. Psoriasis is characterized by erythematous plaque lesions covered in thick gray-white scales, usually have a symmetrical predilection on the elbows, knees, trunk, and scalp. Immunomodulators or immunosuppressants are commonly used for moderate to severe psoriasis. There have been several studies on side effects and recommendations for the necessary dosage adjustments in the era of the COVID-19 pandemic. Careful use is important to maintain patient’s immunity
Terapi Psoriasis di Era Pandemi COVID-19 Marsha Kurniawan; Franklind Matthew
Cermin Dunia Kedokteran Vol 48 No 7 (2021): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i7.90

Abstract

Psoriasis merupakan penyakit inflamasi kronis kulit dengan predisposisi genetik dan autoimun yang kuat. Prevalensi psoriasis di seluruh dunia adalah 0,09% sampai 5,1%, bervariasi antar negara. Psoriasis dikarakteristikkan dengan lesi plak eritematosa yang dilapisi skuama tebal putih keabuan, biasanya memiliki predileksi simestris di siku, lutut, trunk, dan scalp. Terapi sebagian besar menggunakan imunomodulator atau imunosupresan untuk psoriasis derajat sedang hingga berat. Sudah terdapat beberapa penelitian efek samping dan rekomendasi dosis obatobatan di era COVID-19. Penggunaan terapi tersebut dalam era pandemi COVID-19 harus hati-hati dan tetap menjaga imunitas pasien. Psoriasis is a chronic skin inflammatory disease with a strong genetic and autoimmune predisposition. The prevalence of psoriasis worldwide is 0.09% to 5.1%, varies among countries. Psoriasis is characterized by erythematous plaque lesions covered in thick gray-white scales, usually have a symmetrical predilection on the elbows, knees, trunk, and scalp. Immunomodulators or immunosuppressants are commonly used for moderate to severe psoriasis. There have been several studies on side effects and recommendations for the necessary dosage adjustments in the era of the COVID-19 pandemic. Careful use is important to maintain patient’s immunity
Co-Authors Marsha Kurniawan